Join the Journey Towards Understanding and Hope

Learn MoreCall Now

Unlocking the Mysteries of Alzheimer's and Memory Loss

In the United States alone, over 5 million individuals live with Alzheimer's Disease, a number projected to nearly triple by 2050. With someone developing Alzheimer's every 65 seconds, the urgency for breakthrough research and improved treatments has never been greater. 

Alzheimer's, the most common cause of dementia, affects memory, thinking, and behavior profoundly, eventually hindering the ability to perform daily activities. It's crucial to understand that Alzheimer's is not a normal part of aging; it's a progressive disease that intensifies over time, affecting those 65 and older the most significantly.

Understanding Alzheimer's & Memory Loss & Its Impact
 

Alzheimer's disease is marked by its gradual progression from mild memory loss to severe cognitive decline, including the loss of conversational abilities and environmental responsiveness. 

The life expectancy post-diagnosis ranges from 4 to 20 years, heavily influenced by various factors. Despite the absence of a cure, current treatments can slow the progression of dementia symptoms and improve quality of life. 

Now, with a global push towards innovative research, there's a collective effort to discover treatments that can delay onset and prevent the development of Alzheimer's.

Learn MoreCall Now

Explore the Future of 

Alzheimer's & Memory

Loss Research

Learn MoreCall Now

Types of Multiple Sclerosis 

Clinically Isolated Syndrome (CIS)

Relapsing-Remitting
MS (RRMS) 

Secondary Progressive MS (SPMS) 

Primary Progressive
MS (PPMS) 

A first episode of symptoms lasting at least 24 hours,
indicating potential MS development.

Characterized by episodes of
new symptoms followed by periods of remission. Approximately 85% of MS diagnoses are RRMS. 

A progression from RRMS,
where symptoms worsen over time, with or without active relapses. 

From the onset, symptoms gradually worsen without
early relapses or remissions, affecting about 15% of MS patients. 

Recognizing the Symptoms

The journey through Alzheimer's begins with memory lapses, especially in learning new information, as this disease initially impacts the brain's learning center. As Alzheimer's progresses, individuals may experience:

Deepening confusion about time, events, and places

Disorientation

Mood and behavior changes

Unfounded suspicion towards close ones and caregivers

Challenges with speaking, swallowing, and walking

Advanced memory loss and behaviorial shifts

Alzheimer's Disease 
by the Numbers 

01

More than 5 million Americans are currently living with AD

02

Its estimated the number of people living with AD in the US could 3X, reaching 14 million by 2050.

03

Every 65 seconds, someone in the US develops AD.

04

Almost 2/3 of Americans living with AD are women.

The Persuit of 
New Treatments

The quest for a cure has placed Alzheimer's research in the spotlight, exploring every facet of how the disease affects the brain. 

Significant strides have been made in understanding Alzheimer's, and now, the focus is on pioneering treatments that promise a brighter future.

Request More Information

Seeking Participants for Clinical Studies

Are you interested in advancing Alzheimer's /Memory Loss research and exploring new treatment options? Consider joining a clinical study:

Eligibility Criteria: 


Ages 50 - 90 

Experiencing Memory Loss Symptoms 
(Can be diagnosed with Alzheimer's or Lewy Bodies Dementia. If not yet diagnosed, we can screen on-site)

Must come with caregiver to all study visits

Learn MoreCall Now

Study Benefits: 

Transportation provided

Access to Alternative Treatment

Learn MoreCall Now

Compensation: up to $2,000 upon completion of study

Free Screening - No insurance required

Let's take a step forward together in managing Alzheimer's Disease.

For more information and to express your interest in participating in a clinical study, please fill out the form below. 

Together, we can explore new horizons in AD care and treatment.

Join Us in the 
Fight Against 
Alzheimer's &   Memory Loss

 

Request More Information

Your participation in clinical studies could light the path to groundbreaking treatments and a better understanding of Alzheimer's & Memory Loss. 

If you're between 50 and 90 years old, experiencing memory loss and have been diagnosed with Alzheimer's or Lewy Bodies Dementia, you might be eligible to join a study aimed at exploring innovative treatment options.

Copyright © 2024 Clinical Studies Houston

Often, it's the friends and family who first notice these changes, as individuals with Alzheimer's may struggle to recognize their own symptoms.

Your journey towards a better understanding and management of Alzheimer's Disease & Memory Loss starts here. Explore, inquire, and join us in the pursuit of advancing AD research and treatment options.

Seeking Participants for Clinical Studies

Are you interested in advancing Alzheimer's / Memory Loss research and exploring new treatment options? Consider joining a clinical study:

Eligibility Criteria: 


Ages 50 - 90 

Experiencing Memory Loss Symptoms 
(Can be diagnosed with Alzheimer's or Lewy Bodies Dementia. If not yet diagnosed, we can screen on-site)

Must come with caregiver to all study visits

Learn MoreCall Now

Study Benefits: 

Transportation provided

Access to Alternative Treatment

Learn MoreCall Now

Compensation: up to $2,000 upon completion of study

Free Screening - No insurance required

Recognizing the Symptoms

The journey through Alzheimer's begins with memory lapses, especially in learning new information, as this disease initially impacts the brain's learning center. As Alzheimer's progresses, individuals may experience:

Deepening confusion about time, events, and places

Disorientation

Mood and behavior changes

Unfounded suspicion towards close ones and caregivers

Challenges with speaking, swallowing, and walking

Advanced memory loss and behaviorial shifts

Often, it's the friends and family who first notice these changes, as individuals with Alzheimer's may struggle to recognize their own symptoms.